Collaborative platform to elucidate the significance of plasma cell-free DNA concentration

Poster Number: P160
Presentation Time: 05:00 PM - 06:30 PM

Abstract Keywords: Biomarkers, Clinical Decision Support, Data Sharing, Omics (genomics, metabolomics, proteomics, transcriptomics, etc.) and Integrative Analyses, Usability, Bioinformatics
Primary Track: Applications

Plasma cell-free DNA (cfDNA) concentration is expected to be applied in the monitoring of various diseases. We believe that ease of ordering and clarity of result interpretation in clinical practice is necessary to promote its use. We developed the front-end and back-end systems for a measurement service. Not only is this expected to improve sample logistics, but the "clinical workbench" will assist in interpreting patient data using an accumulated anonymized cfDNA data and knowledge base.

Speaker(s):
Teruyoshi Hishiki, MD
Toho University / Crecon Genomics Inc. /